Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected
In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin
DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate
Rauscher Disappointed In CREG Progress
Cancer Commission Surveying for Pill, Hepatoma Association
President Accepts Rauscher Resignation
NCI Urged To Back Ultrasounds Studies
Schmidt Attempted To Answer Critics
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









